Annual Total Debt
$657.70 K
-$107.50 K-14.05%
December 31, 2023
Summary
- As of February 12, 2025, SBFM annual total debt is $657.70 thousand, with the most recent change of -$107.50 thousand (-14.05%) on December 31, 2023.
- During the last 3 years, SBFM annual total debt has fallen by -$1.26 million (-65.62%).
- SBFM annual total debt is now -100.00% below its all-time high of $20.13 billion, reached on December 1, 2003.
Performance
SBFM Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$556.60 K
-$20.80 K-3.60%
September 30, 2024
Summary
- As of February 12, 2025, SBFM quarterly total debt is $556.60 thousand, with the most recent change of -$20.80 thousand (-3.60%) on September 30, 2024.
- Over the past year, SBFM quarterly total debt has dropped by -$116.90 thousand (-17.36%).
- SBFM quarterly total debt is now -84.25% below its all-time high of $3.53 million, reached on September 1, 2021.
Performance
SBFM Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
SBFM Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.1% | -17.4% |
| 3 y3 years | -65.6% | -22.6% |
| 5 y5 years | -31.0% | -22.6% |
SBFM Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -65.4% | at low | -70.7% | -100.0% |
| 5 y | 5-year | -65.6% | at low | -84.3% | -100.0% |
| alltime | all time | -100.0% | -100.0% | -84.3% | -100.0% |
Sunshine Biopharma Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $556.60 K(-3.6%) |
| Jun 2024 | - | $577.40 K(-5.7%) |
| Mar 2024 | - | $612.40 K(-6.9%) |
| Dec 2023 | $657.70 K(-14.0%) | $657.70 K(-2.3%) |
| Sep 2023 | - | $673.50 K(-6.3%) |
| Jun 2023 | - | $718.90 K(-2.1%) |
| Mar 2023 | - | $734.40 K(-4.0%) |
| Dec 2022 | $765.20 K(-59.7%) | $765.20 K(>+9900.0%) |
| Sep 2022 | - | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) |
| Mar 2022 | - | $0.00(-100.0%) |
| Dec 2021 | $1.90 M(-0.7%) | - |
| Dec 2021 | - | $1.90 M(-46.2%) |
| Sep 2021 | - | $3.53 M(+39.8%) |
| Jun 2021 | - | $2.53 M(-7.8%) |
| Mar 2021 | - | $2.74 M(+43.4%) |
| Dec 2020 | $1.91 M(+167.3%) | $1.91 M(+88.3%) |
| Sep 2020 | - | $1.02 M(+61.0%) |
| Jun 2020 | - | $631.00 K(-1.7%) |
| Mar 2020 | - | $641.70 K(-10.3%) |
| Dec 2019 | $715.60 K(-24.9%) | $715.60 K(-4.8%) |
| Sep 2019 | - | $751.70 K(-3.5%) |
| Jun 2019 | - | $778.80 K(-37.2%) |
| Mar 2019 | - | $1.24 M(+30.1%) |
| Dec 2018 | $952.60 K(+18.7%) | $952.60 K(+4.6%) |
| Sep 2018 | - | $910.60 K(-28.5%) |
| Jun 2018 | - | $1.27 M(-6.9%) |
| Mar 2018 | - | $1.37 M(+70.5%) |
| Dec 2017 | $802.30 K(+238.5%) | $802.30 K(+35.6%) |
| Sep 2017 | - | $591.70 K(+46.3%) |
| Jun 2017 | - | $404.50 K(+58.4%) |
| Mar 2017 | - | $255.30 K(+7.7%) |
| Dec 2016 | $237.00 K(-79.2%) | $237.00 K(-4.8%) |
| Sep 2016 | - | $249.00 K(-23.2%) |
| Jun 2016 | - | $324.10 K(-70.7%) |
| Mar 2016 | - | $1.10 M(-3.2%) |
| Dec 2015 | $1.14 M | $1.14 M(+172.5%) |
| Sep 2015 | - | $418.60 K(+7.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $390.60 K(+24.8%) |
| Mar 2015 | - | $313.10 K(-34.8%) |
| Dec 2014 | $480.10 K(+3740.8%) | $480.10 K(+21.2%) |
| Sep 2014 | - | $396.00 K(+40.2%) |
| Jun 2014 | - | $282.50 K(+113.2%) |
| Mar 2014 | - | $132.50 K(+960.0%) |
| Dec 2013 | $12.50 K(-80.0%) | $12.50 K(0.0%) |
| Sep 2013 | - | $12.50 K(0.0%) |
| Jun 2013 | - | $12.50 K(0.0%) |
| Mar 2013 | - | $12.50 K(-80.0%) |
| Dec 2012 | $62.50 K(>+9900.0%) | $62.50 K(+400.0%) |
| Sep 2012 | - | $12.50 K(0.0%) |
| Jun 2012 | - | $12.50 K(0.0%) |
| Mar 2012 | - | $12.50 K(>+9900.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(-100.0%) | - |
| Oct 2009 | - | $0.00(-100.0%) |
| Jul 2009 | $31.00 K(+82.4%) | $31.00 K(+17.0%) |
| Apr 2009 | - | $26.50 K(+20.5%) |
| Jan 2009 | - | $22.00 K(0.0%) |
| Oct 2008 | - | $22.00 K(+29.4%) |
| Jul 2008 | $17.00 K(>+9900.0%) | $17.00 K(+25.9%) |
| Apr 2008 | - | $13.50 K(>+9900.0%) |
| Jan 2008 | - | $0.00(0.0%) |
| Oct 2007 | - | $0.00 |
| Jul 2007 | $0.00(-100.0%) | - |
| Dec 2003 | $20.13 B(+2.2%) | - |
| Dec 2002 | $19.69 B(+238.3%) | - |
| Dec 2001 | $5.82 B(-21.6%) | - |
| Dec 2000 | $7.43 B(-42.6%) | - |
| Dec 1999 | $12.93 B(-6.4%) | - |
| Dec 1998 | $13.81 B | - |
FAQ
- What is Sunshine Biopharma annual total debt?
- What is the all time high annual total debt for Sunshine Biopharma?
- What is Sunshine Biopharma annual total debt year-on-year change?
- What is Sunshine Biopharma quarterly total debt?
- What is the all time high quarterly total debt for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly total debt year-on-year change?
What is Sunshine Biopharma annual total debt?
The current annual total debt of SBFM is $657.70 K
What is the all time high annual total debt for Sunshine Biopharma?
Sunshine Biopharma all-time high annual total debt is $20.13 B
What is Sunshine Biopharma annual total debt year-on-year change?
Over the past year, SBFM annual total debt has changed by -$107.50 K (-14.05%)
What is Sunshine Biopharma quarterly total debt?
The current quarterly total debt of SBFM is $556.60 K
What is the all time high quarterly total debt for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly total debt is $3.53 M
What is Sunshine Biopharma quarterly total debt year-on-year change?
Over the past year, SBFM quarterly total debt has changed by -$116.90 K (-17.36%)